These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 33252197)
1. Cheminformatics Analysis of Fluoroquinolones and their Inhibition Potency Against Four Pathogens. Borrel A; Melander C; Fourches D Mol Inform; 2021 May; 40(5):e2000215. PubMed ID: 33252197 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antibacterial activity of 7-(3-alkoxyimino-5-amino/methylaminopiperidin-1-yl)fluoroquinolone derivatives. Zhang Y; Li G; Liu M; You X; Feng L; Lv K; Cao J; Guo H Bioorg Med Chem Lett; 2011 Feb; 21(3):928-31. PubMed ID: 21232952 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antibacterial activity of new fluoroquinolones containing a cis- or trans-cyclohexane moiety. Qi QR; Pan J; Guo XQ; Weng LL; Liang YF Bioorg Med Chem Lett; 2012 Dec; 22(24):7688-92. PubMed ID: 23102889 [TBL] [Abstract][Full Text] [Related]
4. Discovery of the highly potent fluoroquinolone-based benzothiazolyl-4-thiazolidinone hybrids as antibacterials. Patel RV; Park SW Chem Biol Drug Des; 2014 Jul; 84(1):123-9. PubMed ID: 24524270 [TBL] [Abstract][Full Text] [Related]
6. Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli. Cambau E; Matrat S; Pan XS; Roth Dit Bettoni R; Corbel C; Aubry A; Lascols C; Driot JY; Fisher LM J Antimicrob Chemother; 2009 Mar; 63(3):443-50. PubMed ID: 19147516 [TBL] [Abstract][Full Text] [Related]
7. In vitro spectrum of activity of finafloxacin, a novel, pH-activated fluoroquinolone, under standard and acidic conditions. Stubbings W; Leow P; Yong GC; Goh F; Körber-Irrgang B; Kresken M; Endermann R; Labischinski H Antimicrob Agents Chemother; 2011 Sep; 55(9):4394-7. PubMed ID: 21709094 [TBL] [Abstract][Full Text] [Related]
8. New 7-[4-(4-(un)substituted)piperazine-1-carbonyl]- piperazin-1-yl] derivatives of fluoroquinolone: synthesis and antimicrobial evaluation. Chen PT; Lin WP; Lee AR; Hu MK Molecules; 2013 Jun; 18(7):7557-69. PubMed ID: 23807580 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety. Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, antimicrobial, and DNA gyrase inhibitory properties of fluoroquinolone-dichloroacetic acid hybrids. Seliem IA; Panda SS; Girgis AS; Nagy YI; George RF; Fayad W; Fawzy NG; Ibrahim TS; Al-Mahmoudy AMM; Sakhuja R; Abdel-Samii ZKM Chem Biol Drug Des; 2020 Feb; 95(2):248-259. PubMed ID: 31623026 [TBL] [Abstract][Full Text] [Related]
11. In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone. Morrow BJ; He W; Amsler KM; Foleno BD; Macielag MJ; Lynch AS; Bush K Antimicrob Agents Chemother; 2010 May; 54(5):1955-64. PubMed ID: 20176911 [TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. Stamm JM; Hanson CW; Chu DT; Bailer R; Vojtko C; Fernandes PB Antimicrob Agents Chemother; 1986 Feb; 29(2):193-200. PubMed ID: 3087274 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone derivatives. Chai Y; Wan ZL; Wang B; Guo HY; Liu ML Eur J Med Chem; 2009 Oct; 44(10):4063-9. PubMed ID: 19481308 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens. Kazamori D; Aoi H; Sugimoto K; Ueshima T; Amano H; Itoh K; Kuramoto Y; Yazaki A Int J Antimicrob Agents; 2014 Nov; 44(5):443-9. PubMed ID: 25239276 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, antibacterial activity, and interaction with DNA of the vanadyl-enrofloxacin complex. Efthimiadou EK; Katsaros N; Karaliota A; Psomas G Bioorg Med Chem Lett; 2007 Mar; 17(5):1238-42. PubMed ID: 17196389 [TBL] [Abstract][Full Text] [Related]
17. SAR analysis of new dual targeting fluoroquinolones. Implications of the benzenesulfonyl group. Nieto MJ; Pierini AB; Singh N; McCurdy CR; Manzo RH; Mazzieri MR Med Chem; 2012 May; 8(3):349-60. PubMed ID: 22530906 [TBL] [Abstract][Full Text] [Related]